Global Female Condom Market Trends and Drivers, Restraints, and Opportunities 2017-2023
Female Condom Market – Global Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017–2023
Overview: Birth control has a broad positive impact and has expanded opportunities for women in terms of economic advancements, educational attainment, and improved health outcomes. Female condom is a contraceptive that helps individuals and couples to gain basic right to decide when and how many children to have. The rising adoption of various methods of contraception has resulted in the improvement not only in health-related outcomes but in several economic and social issues. For instance, it has reduced the infant mortality and maternal mortality rates. According to Centers for Disease Control and Prevention (CDC), the introduction toward access to modern contraceptives is among one of the 10 great public health achievements of the 20th century.
The implementation of modern contraceptive methods offers safe provision by eliminating unwanted restrictive practices and medical barriers. The WHO has developed a set of medical eligibility criteria that is based on a collaborative review of all clinical, research, epidemiological, and modern contraceptive methods.
The major products in the market include:
Market Analysis: The Global Female Condom Market is estimated to witness a CAGR of 15.55% during the forecast period 2017–2023.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). The Americas is set to be the leading region for the female condom market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions. The emerging markets have a high potential to grow owing to the highest proportion of young women who need to use modern contraceptives methods. Further, the government is focusing toward improvising healthcare infrastructure and creating awareness among people for early prevention of unintended pregnancies. The government in most of the developing countries are taking initiatives for creating awareness about contraceptives by conducting programs and collaborating with NGOs to have an effective spread of contraceptives in order to reduce poverty and illiteracy caused due to unplanned births. It is encouraging the use of female condoms by supplying them door to door and imparting knowledge to prevent the spread of STDs and restrict population growth. However, few rural areas, and cultural and religious opposition in certain emerging countries, such as China, India, Thailand, Vietnam, Malaysia, and Philippines, hinder the market growth.
Key Players: Church & Dwight CO., Inc., The Female Health Company (now Veru Inc), Cupid Ltd., and PATH, and other predominant & niche players.
Competitive Analysis: The global female condom market has immense growth opportunities for vendors in both developed and developing regions. The market in the developed countries is seeing an increase in the adoption of female condom, especially in the US, Canada, France, Germany, the UK, and few of the developing countries. These countries have the highest number of frequent user population accounting to 70% to 75% of the total female condom population worldwide.
The vendors have a strong focus on understanding the customer base by creating awareness and initiatives to generate knowledge about their products and upcoming technologically-advanced female condoms. The growing awareness about the products and a rise in the number of distributions that have resulted in an increase in the volume of female condoms among individuals will spur the market growth.
Benefits: The report provides complete details about the usage and adoption rate of female condom for birth control, family planning, and to avoid unwanted pregnancies. Therefore, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward contraceptive adoption in the upcoming years. They can also get details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Key Stakeholders:
Overview: Birth control has a broad positive impact and has expanded opportunities for women in terms of economic advancements, educational attainment, and improved health outcomes. Female condom is a contraceptive that helps individuals and couples to gain basic right to decide when and how many children to have. The rising adoption of various methods of contraception has resulted in the improvement not only in health-related outcomes but in several economic and social issues. For instance, it has reduced the infant mortality and maternal mortality rates. According to Centers for Disease Control and Prevention (CDC), the introduction toward access to modern contraceptives is among one of the 10 great public health achievements of the 20th century.
The implementation of modern contraceptive methods offers safe provision by eliminating unwanted restrictive practices and medical barriers. The WHO has developed a set of medical eligibility criteria that is based on a collaborative review of all clinical, research, epidemiological, and modern contraceptive methods.
The major products in the market include:
- TROJAN Her Pleasure
- FC2 female condom
- CUPID female condom
- PATH – Women Condom
Market Analysis: The Global Female Condom Market is estimated to witness a CAGR of 15.55% during the forecast period 2017–2023.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). The Americas is set to be the leading region for the female condom market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions. The emerging markets have a high potential to grow owing to the highest proportion of young women who need to use modern contraceptives methods. Further, the government is focusing toward improvising healthcare infrastructure and creating awareness among people for early prevention of unintended pregnancies. The government in most of the developing countries are taking initiatives for creating awareness about contraceptives by conducting programs and collaborating with NGOs to have an effective spread of contraceptives in order to reduce poverty and illiteracy caused due to unplanned births. It is encouraging the use of female condoms by supplying them door to door and imparting knowledge to prevent the spread of STDs and restrict population growth. However, few rural areas, and cultural and religious opposition in certain emerging countries, such as China, India, Thailand, Vietnam, Malaysia, and Philippines, hinder the market growth.
Key Players: Church & Dwight CO., Inc., The Female Health Company (now Veru Inc), Cupid Ltd., and PATH, and other predominant & niche players.
Competitive Analysis: The global female condom market has immense growth opportunities for vendors in both developed and developing regions. The market in the developed countries is seeing an increase in the adoption of female condom, especially in the US, Canada, France, Germany, the UK, and few of the developing countries. These countries have the highest number of frequent user population accounting to 70% to 75% of the total female condom population worldwide.
The vendors have a strong focus on understanding the customer base by creating awareness and initiatives to generate knowledge about their products and upcoming technologically-advanced female condoms. The growing awareness about the products and a rise in the number of distributions that have resulted in an increase in the volume of female condoms among individuals will spur the market growth.
Benefits: The report provides complete details about the usage and adoption rate of female condom for birth control, family planning, and to avoid unwanted pregnancies. Therefore, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward contraceptive adoption in the upcoming years. They can also get details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Key Stakeholders:
1 INDUSTRY OUTLOOK
1.1 Industry Overview
1.2 Why female Condoms?
1.3 Industry Trends
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.4 Porter 5 (Five) Forces
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Growing incidence of unwanted pregnancies
3.5.1.2 Government and NGOs initiatives
3.5.1.3 Unmet need for contraception in developing countries
3.5.2 Restraints
3.5.2.1 Prolonged regulatory approval of contraceptive devices
3.5.2.2 Availability of alternatives
3.5.2.1 Intense competition among vendors
3.5.2.2 High cost of female condom
3.5.3 Opportunities
3.5.3.1 Increase in prevalence of contraception
3.5.3.2 Rise in effective awareness programs
3.5.3.3 Increase in healthcare spending
3.5.4 DRO – Impact Analysis
3.5.5 Key Stakeholders
4 REGIONS: MARKET SIZE & ANALYSIS
4.1 Overview
4.2 North America
4.2.1 Market Overview
4.3 Europe
4.3.1 Market Overview
4.4 APAC
4.4.1 Market Overview
4.5 Rest of the World
4.5.1 Market Overview
5 COMPETITIVE LANDSCAPE
5.1 Competitor Comparison Analysis
6 VENDOR PROFILES
6.1.1 Church & Dwight Co., Inc.
6.1.1.1 Overview
6.1.1.2 Business focus
6.1.1.3 SWOT analysis
6.1.1.4 Business strategies
6.1.2 The Female Health Company (Veru Inc.)
6.1.2.1 Overview
6.1.2.2 Business units
6.1.2.3 Business focus
6.1.2.4 SWOT analysis
6.1.2.5 Business strategies
6.1.3 Cupid Ltd.
6.1.3.1 Overview
6.1.3.2 Business focus
6.1.3.3 SWOT analysis
6.1.3.4 Business strategies
6.1.4 PATH
6.1.4.1 Overview
6.1.4.2 Business units
6.1.4.3 Business focus
6.1.4.4 SWOT analysis
6.1.4.5 Business strategies
Annexure
Abbreviations
Tables
Table 1 GLOBAL FEMALE CONDOM MARKET REVENUE BY REGIONS, 2016–2023 ($MILLION)
Table 2 DRO (NORTH AMERICA)
Table 3 DRO (EUROPE)
Table 4 DRO (APAC)
Table 5 DRO (REST OF THE WORLD)
Table 1 CHURCH & DWIGHT CO., INC.: PRODUCT OFFERINGS
Table 2 CHURCH & DWIGHT CO., INC.: RECENT DEVELOPMENTS
Table 3 THE FEMALE HEALTH COMPANY: PRODUCT OFFERINGS
Table 4 THE FEMALE HEALTH COMPANY: RECENT DEVELOPMENTS
Table 5 CUPID LTD.: PRODUCT OFFERINGS
Table 6 PATH: PRODUCT OFFERINGS
Table 7 PATH: RECENT DEVELOPMENTS
Charts
Chart 1 GLOBAL CONTRACEPTIVES MARKET, 2016 ($ MILLIONS)
Chart 2 CONTRACEPTIVE PREVALENCE AMONG MARRIED OR IN-UNION WOMEN AGED 15 TO 49 YEARS
Chart 3 PERCENTAGE OF ADOLESCENCE WOMEN AT EACH AGE GROUP IN ALL DEVELOPING REGIONS 2016
Chart 4 PERCENTAGE SPLIT OF 252 MILLION WOMEN AGED 15-19 YEARS, 2016
Chart 5 PERCENTAGE OF MODERN CONTRACEPTION METHODS USAGE AMONG WOMEN AGED 15 TO 49 YEARS (MARRIED OR IN-UNION), 2015
Chart 6 NUMBER OF MARRIED OR IN-UNION WOMEN USING CONTRACEPTION, 2015 (MILLIONS)
Chart 7 DEVELOPMENTS OF CONTRACEPTIVE METHODS
Chart 8 FEMALE CONDOM AND ITS NEED
Chart 10 RESEARCH METHODOLOGY
Chart 11 GLOBAL CONDOM MARKET REVENUE, 2016-2023 ($MILLION)
Chart 12 CONTRACEPTIVE DEVICES MARKET SEGMENTATION
Chart 13 SEGMENTATION OF GLOBAL CONTRACEPTIVES DEVICES MARKET BY TYPE: 2016 IN ($ MILLIONS)
Chart 14 SEGMENTATION OF GLOBAL CONTRACEPTIVES MARKET BY TYPE OF CONDOM: 2016 ($ MILLIONS)
Chart 15 GLOBAL FEMALE CONDOM MARKET REVENUE, 2016-2023 ($MILLION)
Chart 16 PORTERS 5 FORCES ON FEMALE CONDOMS MARKET
Chart 17 MARKET DYNAMICS – DRIVERS, RESTRAINTS, AND OPPORTUNITIES FOR FEMALE CONDOM
Chart 18 THE PERCENTAGE OF THOSE WHO LIMIT BIRTH IS TWICE AS HIGH IN SOUTH CENTRAL ASIA AND SOUTHEAST ASIA WHEN COMPARED TO THOSE WOMEN IN SUB-SAHARAN AFRICA
Chart 19 GLOBAL CONTRACEPTIVE PREVALENCE AMONG MARRIED OR IN-UNION WOMEN AGED 15 TO 49 YEARS, 2015
Chart 20 DRO - IMPACT ANALYSIS OF FEMALE CONDOM MARKET
Chart 21 KEY STAKEHOLDERS
Chart 22 GLOBAL FEMALE CONDOM MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)
Chart 23 GLOBAL FEMALE CONDOM MARKET OVERVIEW BY REGIONS 2016 ($ MILLION)
Chart 24 FEMALE CONDOM MARKET REVENUE IN NORTH AMERICA, 2016–2023 ($MILLION)
Chart 25 FEMALE CONDOM MARKET REVENUE IN EUROPE, 2016–2023 ($MILLION)
Chart 26 FEMALE CONDOM MARKET REVENUE IN APAC, 2016–2023 ($MILLION)
Chart 27 FEMALE CONDOM MARKET REVENUE IN THE REST OF THE WORLD, 2017–2023 ($MILLION)
Chart 28 GLOBAL FEMALE CONDOM MARKET SEGMENTATION BY GEOGRAPHY, 2016-2023 ($MILLION)
Chart 29 GLOBAL FEMALE CONDOM MARKET SEGMENTATION BY GEOGRAPHY, 2016-2023 (% SHARE)
Chart 30 CHURCH & DWIGHT CO., INC.: OVERVIEW SNAPSHOT
Chart 31 CHURCH & DWIGHT CO., INC.: BUSINESS UNITS
Chart 32 CHURCH & DWIGHT CO., INC.: SWOT ANALYSIS
Chart 33 THE FEMALE HEALTH COMPANY: OVERVIEW SNAPSHOT
Chart 34 THE FEMALE HEALTH COMPANY: OPERATES IN FOREIGN AND DOMESTIC REGIONS
Chart 35 THE FEMALE HEALTH COMPANY: SWOT ANALYSIS
Chart 36 CUPID LTD.: OVERVIEW SNAPSHOT
Chart 37 CUPID LTD: SWOT ANALYSIS
Chart 38 PATH: OVERVIEW SNAPSHOT
Chart 39 PATH: FINANCES – SOURCES OF REVENUE
Chart 40 PATH: FINANCES – USE OF FUNDS
Chart 41 PATH: FINANCES – EXPENSE ALLOCATION
Chart 42 PATH: SWOT ANALYSIS
1.1 Industry Overview
1.2 Why female Condoms?
1.3 Industry Trends
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.4 Porter 5 (Five) Forces
3.5 Market Dynamics
3.5.1 Drivers
3.5.1.1 Growing incidence of unwanted pregnancies
3.5.1.2 Government and NGOs initiatives
3.5.1.3 Unmet need for contraception in developing countries
3.5.2 Restraints
3.5.2.1 Prolonged regulatory approval of contraceptive devices
3.5.2.2 Availability of alternatives
3.5.2.1 Intense competition among vendors
3.5.2.2 High cost of female condom
3.5.3 Opportunities
3.5.3.1 Increase in prevalence of contraception
3.5.3.2 Rise in effective awareness programs
3.5.3.3 Increase in healthcare spending
3.5.4 DRO – Impact Analysis
3.5.5 Key Stakeholders
4 REGIONS: MARKET SIZE & ANALYSIS
4.1 Overview
4.2 North America
4.2.1 Market Overview
4.3 Europe
4.3.1 Market Overview
4.4 APAC
4.4.1 Market Overview
4.5 Rest of the World
4.5.1 Market Overview
5 COMPETITIVE LANDSCAPE
5.1 Competitor Comparison Analysis
6 VENDOR PROFILES
6.1.1 Church & Dwight Co., Inc.
6.1.1.1 Overview
6.1.1.2 Business focus
6.1.1.3 SWOT analysis
6.1.1.4 Business strategies
6.1.2 The Female Health Company (Veru Inc.)
6.1.2.1 Overview
6.1.2.2 Business units
6.1.2.3 Business focus
6.1.2.4 SWOT analysis
6.1.2.5 Business strategies
6.1.3 Cupid Ltd.
6.1.3.1 Overview
6.1.3.2 Business focus
6.1.3.3 SWOT analysis
6.1.3.4 Business strategies
6.1.4 PATH
6.1.4.1 Overview
6.1.4.2 Business units
6.1.4.3 Business focus
6.1.4.4 SWOT analysis
6.1.4.5 Business strategies
Annexure
Abbreviations
Tables
Table 1 GLOBAL FEMALE CONDOM MARKET REVENUE BY REGIONS, 2016–2023 ($MILLION)
Table 2 DRO (NORTH AMERICA)
Table 3 DRO (EUROPE)
Table 4 DRO (APAC)
Table 5 DRO (REST OF THE WORLD)
Table 1 CHURCH & DWIGHT CO., INC.: PRODUCT OFFERINGS
Table 2 CHURCH & DWIGHT CO., INC.: RECENT DEVELOPMENTS
Table 3 THE FEMALE HEALTH COMPANY: PRODUCT OFFERINGS
Table 4 THE FEMALE HEALTH COMPANY: RECENT DEVELOPMENTS
Table 5 CUPID LTD.: PRODUCT OFFERINGS
Table 6 PATH: PRODUCT OFFERINGS
Table 7 PATH: RECENT DEVELOPMENTS
Charts
Chart 1 GLOBAL CONTRACEPTIVES MARKET, 2016 ($ MILLIONS)
Chart 2 CONTRACEPTIVE PREVALENCE AMONG MARRIED OR IN-UNION WOMEN AGED 15 TO 49 YEARS
Chart 3 PERCENTAGE OF ADOLESCENCE WOMEN AT EACH AGE GROUP IN ALL DEVELOPING REGIONS 2016
Chart 4 PERCENTAGE SPLIT OF 252 MILLION WOMEN AGED 15-19 YEARS, 2016
Chart 5 PERCENTAGE OF MODERN CONTRACEPTION METHODS USAGE AMONG WOMEN AGED 15 TO 49 YEARS (MARRIED OR IN-UNION), 2015
Chart 6 NUMBER OF MARRIED OR IN-UNION WOMEN USING CONTRACEPTION, 2015 (MILLIONS)
Chart 7 DEVELOPMENTS OF CONTRACEPTIVE METHODS
Chart 8 FEMALE CONDOM AND ITS NEED
Chart 10 RESEARCH METHODOLOGY
Chart 11 GLOBAL CONDOM MARKET REVENUE, 2016-2023 ($MILLION)
Chart 12 CONTRACEPTIVE DEVICES MARKET SEGMENTATION
Chart 13 SEGMENTATION OF GLOBAL CONTRACEPTIVES DEVICES MARKET BY TYPE: 2016 IN ($ MILLIONS)
Chart 14 SEGMENTATION OF GLOBAL CONTRACEPTIVES MARKET BY TYPE OF CONDOM: 2016 ($ MILLIONS)
Chart 15 GLOBAL FEMALE CONDOM MARKET REVENUE, 2016-2023 ($MILLION)
Chart 16 PORTERS 5 FORCES ON FEMALE CONDOMS MARKET
Chart 17 MARKET DYNAMICS – DRIVERS, RESTRAINTS, AND OPPORTUNITIES FOR FEMALE CONDOM
Chart 18 THE PERCENTAGE OF THOSE WHO LIMIT BIRTH IS TWICE AS HIGH IN SOUTH CENTRAL ASIA AND SOUTHEAST ASIA WHEN COMPARED TO THOSE WOMEN IN SUB-SAHARAN AFRICA
Chart 19 GLOBAL CONTRACEPTIVE PREVALENCE AMONG MARRIED OR IN-UNION WOMEN AGED 15 TO 49 YEARS, 2015
Chart 20 DRO - IMPACT ANALYSIS OF FEMALE CONDOM MARKET
Chart 21 KEY STAKEHOLDERS
Chart 22 GLOBAL FEMALE CONDOM MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)
Chart 23 GLOBAL FEMALE CONDOM MARKET OVERVIEW BY REGIONS 2016 ($ MILLION)
Chart 24 FEMALE CONDOM MARKET REVENUE IN NORTH AMERICA, 2016–2023 ($MILLION)
Chart 25 FEMALE CONDOM MARKET REVENUE IN EUROPE, 2016–2023 ($MILLION)
Chart 26 FEMALE CONDOM MARKET REVENUE IN APAC, 2016–2023 ($MILLION)
Chart 27 FEMALE CONDOM MARKET REVENUE IN THE REST OF THE WORLD, 2017–2023 ($MILLION)
Chart 28 GLOBAL FEMALE CONDOM MARKET SEGMENTATION BY GEOGRAPHY, 2016-2023 ($MILLION)
Chart 29 GLOBAL FEMALE CONDOM MARKET SEGMENTATION BY GEOGRAPHY, 2016-2023 (% SHARE)
Chart 30 CHURCH & DWIGHT CO., INC.: OVERVIEW SNAPSHOT
Chart 31 CHURCH & DWIGHT CO., INC.: BUSINESS UNITS
Chart 32 CHURCH & DWIGHT CO., INC.: SWOT ANALYSIS
Chart 33 THE FEMALE HEALTH COMPANY: OVERVIEW SNAPSHOT
Chart 34 THE FEMALE HEALTH COMPANY: OPERATES IN FOREIGN AND DOMESTIC REGIONS
Chart 35 THE FEMALE HEALTH COMPANY: SWOT ANALYSIS
Chart 36 CUPID LTD.: OVERVIEW SNAPSHOT
Chart 37 CUPID LTD: SWOT ANALYSIS
Chart 38 PATH: OVERVIEW SNAPSHOT
Chart 39 PATH: FINANCES – SOURCES OF REVENUE
Chart 40 PATH: FINANCES – USE OF FUNDS
Chart 41 PATH: FINANCES – EXPENSE ALLOCATION
Chart 42 PATH: SWOT ANALYSIS
